Pharmaceutical - Financial

Filter

Current filters:

Financial

Popular Filters

1 to 25 of 1107 results

Merck strengthens commitment to Chinese growth market

Merck strengthens commitment to Chinese growth market

23-07-2014

Germany’s Merck KGaA, a leading company for high-tech products in the pharmaceutical and chemical sectors,…

ChinaFinancialMerckMerck KGaAPharmaceuticalProductionResearch

Valeant takes Allergan's 'false and misleading statements' to Quebec and US financial regulators

Valeant takes Allergan's 'false and misleading statements' to Quebec and US financial regulators

22-07-2014

In the latest in an ongoing takeover attempt of Allergan by Valeant, Valeant has contacted financial…

AllerganBausch & LombCanadaFinancialPharmaceuticalRegulationUSAValeant Pharmaceuticals

Allergan reports strong 2nd-qtr figures but still plan to cut 1,500 jobs worldwide

Allergan reports strong 2nd-qtr figures but still plan to cut 1,500 jobs worldwide

21-07-2014

Botox maker Allergan has reported its second quarter operating results while also announcing that it…

AllerganAllerganBotoxFinancialPharmaceuticalUSA

Shire’s strong 2nd-qtr financials justify holding out for higher AbbVie bid

Shire’s strong 2nd-qtr financials justify holding out for higher AbbVie bid

18-07-2014

Ireland-headquartered drugmaker Shire, which has just accepted an increased $54 billion bid from the…

AbbVieFinancialIrelandPharmaceuticalShire

Partnerships in Latin America big business between 2009 and 2013

Partnerships in Latin America big business between 2009 and 2013

18-07-2014

Traditional partnerships (excluding mergers, acquisitions and early venture funding) where a Latin American…

BiotechnologyBusiness FinanceFinancialPharmaceuticalSouth America

Elder to strengthen existing brands following sale to Torrent

Elder to strengthen existing brands following sale to Torrent

18-07-2014

Indian drugmaker Elder Pharma has said it plans to strengthen its existing brands including Eldervit…

Elder PharmaceuticalsFinancialIndiaPharmaceuticalTorrent GroupTorrent Pharmaceuticals

Sobi revenues up 27% in 2nd-qtr 2014

Sobi revenues up 27% in 2nd-qtr 2014

18-07-2014

Biotech firm Swedish Orphan Biovitrum, announced total revenues of 662.5 million Swedish kronor ($97…

FinancialOrfadinPharmaceuticalSobiSwedish Orphan Biovitrum

Report: US state governments may spend $55 billion on hepatitis C drugs

Report: US state governments may spend $55 billion on hepatitis C drugs

17-07-2014

State legislatures in the USA will need to find billions in their budgets to purchase costly new hepatitis…

Anti-viralsExpress ScriptsFinancialGilead SciencesHealthcarePharmaceuticalSovaldiUSA

Baxter exceeds own predictions in 2nd-quarter

Baxter exceeds own predictions in 2nd-quarter

17-07-2014

US drugmaker Baxter International reported strong growth across its global franchises in the second quarter…

Baxter InternationalFinancialFundamental analysisPharmaceuticalUSAValuation

Abbott Labs 2nd-quarter revenues rise 1.9%

Abbott Labs 2nd-quarter revenues rise 1.9%

17-07-2014

US health care company Abbott Laboratories, which since its spin-out of its research-based prescription…

Abbott LaboratoriesFinancialPharmaceutical

Novartis 2nd-qtr sales and net profit up but miss analysts’ forecasts

Novartis 2nd-qtr sales and net profit up but miss analysts’ forecasts

17-07-2014

Switzerland’s Novartis – now the world’s largest pharmaceutical company by sales - this morning…

AlconFinancialNovartisPharmaceuticalSandoz

BTG on track in 2nd-qtr financials

BTG on track in 2nd-qtr financials

16-07-2014

UK-based specialist health care company BTG has announced its interim management statement for the period…

BTGFinancialPharmaceuticalUKVarithena

New products drive 2nd-qtr growth for Johnson & Johnson

New products drive 2nd-qtr growth for Johnson & Johnson

15-07-2014

Global health care products giant Johnson & Johnson, the first pharma to report second-quarter 2014 financial…

Business FinanceFinancialJohnson & JohnsonMonoclonal antibodiesPharmaceuticalPrednisoneUSA

New Zealand to fund Norgine’s Xifaxan for hepatic encephalopathy

New Zealand to fund Norgine’s Xifaxan for hepatic encephalopathy

15-07-2014

New Zealand Pharmaceutical Management Agency PHARMAC has awarded a tender to Netherlands-headquartered…

Antibiotics and Infectious diseasesFinancialHealthcareNew ZealandNorginePharmaceuticalXifaxan

Shire succumbs to AbbVie’s yet again increased offer of £53.20 per share

Shire succumbs to AbbVie’s yet again increased offer of £53.20 per share

14-07-2014

Ireland-headquartered Shire, which just on Friday confirmed it had finally entered talks with suitor…

AbbVieAdalimumabFinancialIrelandMergers & AcquisitionsPharmaceuticalShireUSA

Servier to appeal EC fine over perindopril

Servier to appeal EC fine over perindopril

11-07-2014

French privately-held drugmaker Servier has said it will appeal before the European Union Court of Justice…

Cardio-vascularEuropeFinancialLegalPerindoprilperindoprilPharmaceuticalServier

A$35 million to advance Australian type 1 juvenile diabetes research

A$35 million to advance Australian type 1 juvenile diabetes research

10-07-2014

Australia’s Minister for Education, Christopher Pyne, and Minister for Health, Peter Dutton, have today…

AustraliaDiabetesFinancialPharmaceuticalResearch

New Zealand proposes contestable fund for medicines for rare disorders

New Zealand proposes contestable fund for medicines for rare disorders

09-07-2014

New Zealand’s Pharmaceutical Management Agency PHARMAC will be running a commercial process to fund…

FinancialNew ZealandPharmaceuticalRare diseasesRegulation

Bayer milestone for Compugen in cancer immunotherapy deal

Bayer milestone for Compugen in cancer immunotherapy deal

07-07-2014

Shares of Israel-based Compugen rose nearly 4% in pre-market trading today, after it said it has achieved…

BayerCompugenFinancialOncologyPharmaceuticalResearch

Isis Pharma earns $1 million GSK milestone on hepatitis B virus program

Isis Pharma earns $1 million GSK milestone on hepatitis B virus program

03-07-2014

USA-based Isis Pharmaceuticals has earned yet another $1 million payment from UK pharma giant GlaxoSmithKline,…

Anti-viralsFinancialGlaxoSmithKlineIsis PharmaceuticalsPharmaceuticalResearch

New OECD data shows Australia lagging in investing in medicines

New OECD data shows Australia lagging in investing in medicines

03-07-2014

Data newly released by the Organization for Economic Cooperation and Development (OECD) reveals that…

AustraliaFinancialHealthcarePharmaceutical

Chronic under-reporting of pharma R&D investment works against Canada

Chronic under-reporting of pharma R&D investment works against Canada

30-06-2014

A new KPMG study shows that R&D investments made by Canada's innovative pharmaceutical sector continue…

ApostropheCADCanadaEnglish spellingFinancialPharmaceuticalPharmaceutical sectorPoliticsPunctuationResearch

1 to 25 of 1107 results

Back to top